MiMedx Group (MDXG) Guides FY16 Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Canaccord Genuity Raises Price target on MiMedx Group (MDXG) Following 2016 Guidance Release
December 18, 2015 8:48 AM ESTCanaccord Genuity reiterated a Buy rating on MiMedx Group (NASDAQ: MDXG), and raised the price target to $12.00 (from $10.00), following the company's release of 2016 guidance. Revenue guidance of $245M-255M equates to 30-38% growth. MiMedx noted that growth in wound care would continue... More



